Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators: A Review for Clinicians

Satnam Singh, Konstantin Schwarz, John Horowitz, Michael Frenneaux*

*Corresponding author for this work

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cardiac energetic impairment is a frequent finding in patients with both inherited and acquired diseases of heart muscle. In this review the mechanisms of energy generation in the healthy heart and their disturbances in heart muscle diseases are described. Therapeutic agents targeted at correcting cardiac energetic impairment are discussed.

Original languageEnglish
Pages (from-to)720-728
Number of pages9
JournalCirculation. Cardiovascular Genetics
Volume7
Issue number5
DOIs
Publication statusPublished - Oct 2014

Keywords

  • drug therapy
  • energy metabolism
  • perhexiline
  • reperfusion injury
  • fatty-acid oxidation
  • idiopathic dilated cardiomyopathy
  • left-ventricular performance
  • coenzyme-A decarboxylase
  • failing human heart
  • glucose-oxidation
  • creatine-kinase
  • hypertrophic cardiomyopathy
  • uncoupling proteins
  • double-blind

Cite this

Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators : A Review for Clinicians. / Singh, Satnam; Schwarz, Konstantin; Horowitz, John; Frenneaux, Michael.

In: Circulation. Cardiovascular Genetics, Vol. 7, No. 5, 10.2014, p. 720-728.

Research output: Contribution to journalArticle

@article{77417f3479ef4152bac547c7ae8af34e,
title = "Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators: A Review for Clinicians",
abstract = "Cardiac energetic impairment is a frequent finding in patients with both inherited and acquired diseases of heart muscle. In this review the mechanisms of energy generation in the healthy heart and their disturbances in heart muscle diseases are described. Therapeutic agents targeted at correcting cardiac energetic impairment are discussed.",
keywords = "drug therapy, energy metabolism, perhexiline, reperfusion injury, fatty-acid oxidation, idiopathic dilated cardiomyopathy, left-ventricular performance, coenzyme-A decarboxylase, failing human heart, glucose-oxidation, creatine-kinase, hypertrophic cardiomyopathy, uncoupling proteins, double-blind",
author = "Satnam Singh and Konstantin Schwarz and John Horowitz and Michael Frenneaux",
year = "2014",
month = "10",
doi = "10.1161/CIRCGENETICS.114.000221",
language = "English",
volume = "7",
pages = "720--728",
journal = "Circulation. Cardiovascular Genetics",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators

T2 - A Review for Clinicians

AU - Singh, Satnam

AU - Schwarz, Konstantin

AU - Horowitz, John

AU - Frenneaux, Michael

PY - 2014/10

Y1 - 2014/10

N2 - Cardiac energetic impairment is a frequent finding in patients with both inherited and acquired diseases of heart muscle. In this review the mechanisms of energy generation in the healthy heart and their disturbances in heart muscle diseases are described. Therapeutic agents targeted at correcting cardiac energetic impairment are discussed.

AB - Cardiac energetic impairment is a frequent finding in patients with both inherited and acquired diseases of heart muscle. In this review the mechanisms of energy generation in the healthy heart and their disturbances in heart muscle diseases are described. Therapeutic agents targeted at correcting cardiac energetic impairment are discussed.

KW - drug therapy

KW - energy metabolism

KW - perhexiline

KW - reperfusion injury

KW - fatty-acid oxidation

KW - idiopathic dilated cardiomyopathy

KW - left-ventricular performance

KW - coenzyme-A decarboxylase

KW - failing human heart

KW - glucose-oxidation

KW - creatine-kinase

KW - hypertrophic cardiomyopathy

KW - uncoupling proteins

KW - double-blind

U2 - 10.1161/CIRCGENETICS.114.000221

DO - 10.1161/CIRCGENETICS.114.000221

M3 - Article

VL - 7

SP - 720

EP - 728

JO - Circulation. Cardiovascular Genetics

JF - Circulation. Cardiovascular Genetics

SN - 1942-325X

IS - 5

ER -